Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurotransmitters, temperament and social functioning.

A J Bond1

  • 1Section of Clinical Psychopharmacology, Institute of Psychiatry, Kings College London, De Crespigny Park, SE5 8AF, London, UK. a.bond@iop.kcl.ac.uk

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|September 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Future for Protected Areas? Analysing the Mismatch between South Africa's Pre-existing Protected areas System and the Declared vision in Contemporary Conservation Policy.

Environmental management·2024
Same author

Effect of rate of substitution of processed, urea-treated whole-crop wheat for grass silage on the intake, milk production and diet digestibility in dairy cows and ruminal metabolism in vitro.

Animal : an international journal of animal bioscience·2012
Same author

The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Commentary on 'Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation?'.

Journal of psychopharmacology (Oxford, England)·2012
Same author

An experimental study of aggressive and neutral interpretative bias in opiate-dependent and opiate-abstinent men.

Journal of psychopharmacology (Oxford, England)·2008
Same author

Noradrenaline might enhance assertive human social behaviours: an investigation in a flatmate relationship.

Pharmacopsychiatry·2006

Neurochemical pathways influence personality dimensions, impacting treatment outcomes. Pharmacological interventions can alter personality traits, suggesting a link between neurotransmitters and social behavior.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Genetics

Background:

  • Dimensional models offer frameworks for understanding normal and disordered personality.
  • Psychobiological models are supported by evidence from molecular genetics and neurochemistry.
  • Cloninger's personality theory requires further validation regarding specificity.

Purpose of the Study:

  • To investigate the neurochemical basis of personality dimensions.
  • To explore the impact of pharmacological treatments on personality traits.
  • To examine the relationship between personality dimensions, social adaptation, and neurotransmitter systems.

Main Methods:

  • Review of studies in molecular genetics, receptor binding, and pharmacological challenges.
  • Analysis of clinical studies on personality changes during pharmacological treatment.

Related Experiment Videos

  • Examination of evidence linking character dimensions to serotonergic and noradrenergic systems.

    • Main Results:

    • Pharmacological treatments can improve both temperament and character dimensions, particularly in responders.
    • Personality changes observed during treatment can be independent of clinical improvement and occur in healthy individuals.
    • Evidence suggests links between character dimensions, social adaptation, and serotonergic actions, with noradrenaline affecting self-perception and social motivation.

    Conclusions:

    • Neurotransmitter systems, including serotonin and noradrenaline, play a significant role in shaping personality dimensions and social behavior.
    • Personality models can aid in predicting treatment outcomes, though individual dimensions may have limited predictive utility.
    • Specific pharmacological agents targeting different neurotransmitters may induce distinct patterns of personality and social behavior modification.